Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Compounded Drugs Are Not New, Unapproved, Court Rules

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA does not have the authority to regulate compounded preparations as new drugs, court says.

You may also be interested in...



Compounded Drugs Ruling Blocking FDA Enforcement Emphasizes Local Regulation

However, judge denies plaintiffs’ request for injunction barring FDA from declaring compounded drugs new and conducting detailed inspections of certain pharmacies.

Compounded Drugs Ruling Blocking FDA Enforcement Emphasizes Local Regulation

However, judge denies plaintiffs’ request for injunction barring FDA from declaring compounded drugs new and conducting detailed inspections of certain pharmacies.

FDA Cracks Down On Three Pharmacies Compounding Inhalation Drugs

In warning letters to the pharmacies, FDA says their compounding of mass amounts of drugs goes “well beyond” traditional compounding.

Related Content

Topics

UsernamePublicRestriction

Register

PS064228

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel